{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:06:57Z","timestamp":1792516017941,"version":"4.5.0"},"reference-count":175,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jhep.2013.04.004","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T23:15:40Z","timestamp":1365462940000},"page":"595-612","source":"Crossref","is-referenced-by-count":139,"title":["Monogenic diseases that can be cured by liver transplantation"],"prefix":"10.1016","volume":"59","author":[{"given":"Stefano","family":"Fagiuoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Daina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"D\u2019Antiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Colledan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.04.004_b0005","unstructured":"Online Mendelian Inheritance in Man; 2012."},{"key":"10.1016\/j.jhep.2013.04.004_b0010","unstructured":"Genes and human disease. Monogenic diseases; 2012."},{"key":"10.1016\/j.jhep.2013.04.004_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000321767","article-title":"The impact of single gene and chromosomal disorders on hospital admissions of children and adolescents: a population-based study","volume":"14","author":"Dye","year":"2011","journal-title":"Public Health Genomics"},{"key":"10.1016\/j.jhep.2013.04.004_b0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12687-011-0043-3","article-title":"The impact of single gene and chromosomal disorders on hospital admissions in an adult population","volume":"2","author":"Dye","year":"2011","journal-title":"J Community Genet"},{"key":"10.1016\/j.jhep.2013.04.004_b0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jamda.2007.02.008","article-title":"Genetic disorders and congenital malformations in pediatric long-term care","volume":"8","author":"O\u2019Malley","year":"2007","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jhep.2013.04.004_b0030","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1542\/peds.95.5.678","article-title":"Contribution of heritable disorders to mortality in the pediatric intensive care unit","volume":"95","author":"Cunniff","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhep.2013.04.004_b0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajmg.a.20409","article-title":"Contribution of malformations and genetic disorders to mortality in a children\u2019s hospital","volume":"126A","author":"Stevenson","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jhep.2013.04.004_b0040","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MOP.0b013e32834c20d9","article-title":"Enzyme replacement therapy for lysosomal storage diseases","volume":"23","author":"Lachmann","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jhep.2013.04.004_b0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jhep.2013.04.004_b0050","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/S0140-6736(08)60874-0","article-title":"Gene therapy of inherited diseases","volume":"371","author":"Fischer","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.04.004_b0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cld.2007.04.002","article-title":"Liver transplantation for metabolic liver diseases","volume":"11","author":"Zhang","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2013.04.004_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-4-1","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Davit-Spraul","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2013.04.004_b0065","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/01.tp.0000282869.94152.4f","article-title":"Liver transplantation in children with progressive familial intrahepatic cholestasis","volume":"84","author":"Englert","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.04.004_b0070","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1399-3046.2011.01528.x","article-title":"Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma","volume":"15","author":"Romano","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0075","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0168-8278(03)00286-1","article-title":"Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation","volume":"39","author":"Lykavieris","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.04.004_b0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3476(87)80153-1","article-title":"Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases","volume":"110","author":"Alagille","year":"1987","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2013.04.004_b0085","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/hep.510290331","article-title":"Features of Alagille syndrome in 92 patients: frequency and relation to prognosis","volume":"29","author":"Emerick","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.004_b0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/gut.49.3.431","article-title":"Outcome of liver disease in children with Alagille syndrome: a study of 163 patients","volume":"49","author":"Lykavieris","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2013.04.004_b0095","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/lt.23437","article-title":"Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience","volume":"18","author":"Kamath","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.04.004_b0100","first-page":"1318","article-title":"Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations","volume":"57","author":"Figus","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jhep.2013.04.004_b0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","article-title":"EASL Clinical Practice Guidelines: Wilson\u2019s disease","volume":"56","author":"European Association for Study of Liver","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.04.004_b0110","doi-asserted-by":"crossref","first-page":"720","DOI":"10.7326\/0003-4819-115-9-720","article-title":"Wilson disease: clinical presentation, treatment, and survival","volume":"115","author":"Stremmel","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","article-title":"Diagnosis and phenotypic classification of Wilson disease","volume":"23","author":"Ferenci","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.04.004_b0120","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/hep.1840120526","article-title":"Perspectives on Wilson\u2019s disease","volume":"12","author":"Sternlieb","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.004_b0125","first-page":"197","article-title":"Chelation treatment of neurological Wilson\u2019s disease","volume":"86","author":"Walshe","year":"1993","journal-title":"Q J Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0130","first-page":"609","article-title":"Long-term treatment of Wilson\u2019s disease with triethylene tetramine dihydrochloride (trientine)","volume":"88","author":"Dahlman","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.jhep.2013.04.004_b0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneur.60.3.379","article-title":"Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy","volume":"60","author":"Brewer","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jhep.2013.04.004_b0140","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/01.mcg.0000225670.91722.59","article-title":"Diagnosis and management of Wilson\u2019s disease: results of a single center experience","volume":"40","author":"Medici","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2013.04.004_b0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/lt.20352","article-title":"Wilson\u2019s disease in children: 37-year experience and revised King\u2019s score for liver transplantation","volume":"11","author":"Dhawan","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.04.004_b0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0168-8278(95)80194-4","article-title":"Liver transplantation for Wilson\u2019s disease","volume":"23","author":"Bellary","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.04.004_b0155","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/lt.20486","article-title":"Liver transplantation for Wilson\u2019s disease: the burden of neurological and psychiatric disorders","volume":"11","author":"Medici","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.04.004_b0160","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1111\/j.1399-0012.2010.01327.x","article-title":"Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults","volume":"25","author":"Arnon","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1665-2681(19)32138-6","article-title":"Liver transplantation for Wilsons disease: our experience with review of the literature","volume":"2","author":"Podgaetz","year":"2003","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2013.04.004_b0170","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1590-8658(02)80207-9","article-title":"Liver transplantation: the Italian experience","volume":"34","author":"Fagiuali","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2013.04.004_b0175","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/01.TP.0000055830.82799.B1","article-title":"Liver transplantation for Wilson\u2019s disease: long-term results and quality-of-life assessment","volume":"75","author":"Sutcliffe","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.04.004_b0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1399-0012.1997.tb00809.x","article-title":"Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson\u2019s disease","volume":"11","author":"Schumacher","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0185","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1016\/S0041-1345(98)01048-3","article-title":"Recovery of neurological deficits in a case of Wilson\u2019s disease after liver transplantation","volume":"30","author":"Lui","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2013.04.004_b0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3727\/000000005783983250","article-title":"Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1","volume":"14","author":"Ambrosino","year":"2005","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1034\/j.1399-3046.1999.00014.x","article-title":"Living related liver transplantation from heterozygote genetic carriers to children with Wilson\u2019s disease","volume":"3","author":"Asonuma","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/TP.0b013e3181919984","article-title":"Long-term outcomes for 32 cases of Wilson\u2019s disease after living-donor liver transplantation","volume":"87","author":"Yoshitoshi","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.04.004_b0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/shem.2002.35634","article-title":"Hereditary hemochromatosis","volume":"39","author":"Ajioka","year":"2002","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jhep.2013.04.004_b0880","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/j.gastro.2010.06.013","article-title":"Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment","volume":"139","author":"Pietrangelo","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.04.004_b0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jhep.2010.08.004","article-title":"Hepcidin in human iron disorders: therapeutic implications","volume":"54","author":"Pietrangelo","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.04.004_b0220","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/ijms13021497","article-title":"Molecular diagnostic and pathogenesis of hereditary hemochromatosis","volume":"13","author":"Santos","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2013.04.004_b0225","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1182\/blood.V93.8.2502","article-title":"HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis","volume":"93","author":"Mura","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.04.004_b0230","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1478-3231.2011.02606.x","article-title":"Hepatic iron overload following liver transplantation of a C282y homozygous allograft: a case report and literature review","volume":"31","author":"Dwyer","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.04.004_b0235","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron overload cardiomyopathy in clinical practice","volume":"124","author":"Kremastinos","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2013.04.004_b0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2010.03.001","article-title":"EASL clinical practice guidelines for HFE hemochromatosis","volume":"53","author":"European Association for the Study of the Liver","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.04.004_b0245","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.cca.2011.04.007","article-title":"Hereditary hemochromatosis: laboratory evaluation","volume":"412","author":"Moyer","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jhep.2013.04.004_b0250","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1053\/gast.1996.v110.agast961304","article-title":"Hemochromatosis: the impact of early diagnosis and therapy","volume":"110","author":"Powell","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.04.004_b0255","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/lt.500010408","article-title":"Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis","volume":"1","author":"Kowdley","year":"1995","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.jhep.2013.04.004_b0260","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/jlts.2001.25359","article-title":"Liver transplantation for hereditary hemochromatosis","volume":"7","author":"Brandhagen","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.04.004_b0265","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM198511143132004","article-title":"Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis","volume":"313","author":"Niederau","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0270","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/TP.0b013e3181ac60db","article-title":"Combined heart and liver transplantation: a single-center experience","volume":"88","author":"Raichlin","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.04.004_b0275","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.510310227","article-title":"Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation","volume":"31","author":"Brandhagen","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.004_b0280","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/hep.1840200221","article-title":"Outcome of liver transplantation in patients with hemochromatosis","volume":"20","author":"Farrell","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.004_b0285","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.gastro.2005.05.004","article-title":"Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry","volume":"129","author":"Kowdley","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.04.004_b0290","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.20242","article-title":"Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis","volume":"39","author":"Crawford","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.004_b0295","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1432-2277.2009.00863.x","article-title":"Outcome of liver transplantation in hereditary hemochromatosis","volume":"22","author":"Dar","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2013.04.004_b0300","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/j.gastro.2007.05.054","article-title":"Survival of liver transplant recipients with hemochromatosis in the United States","volume":"133","author":"Yu","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.04.004_b0305","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/lt.500050503","article-title":"Long-term follow-up after liver transplantation in patients with hepatic iron overload","volume":"5","author":"Tung","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.jhep.2013.04.004_b0310","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/jhep.2000.20348","article-title":"Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation","volume":"32","author":"Stuart","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.004_b0315","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/TP.0b013e31819f2280","article-title":"Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure","volume":"87","author":"Fenton","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.04.004_b0320","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1073\/pnas.74.10.4641","article-title":"On the enzymic defects in hereditary tyrosinemia","volume":"74","author":"Lindblad","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.04.004_b0325","first-page":"302","article-title":"Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenay-Lac-St-Jean","volume":"47","author":"De Braekeleer","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jhep.2013.04.004_b0330","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM199002153220704","article-title":"Neurologic crises in hereditary tyrosinemia","volume":"322","author":"Mitchell","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0335","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase","volume":"340","author":"Lindstedt","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.04.004_b0340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","article-title":"NTBC treatment in tyrosinaemia type I: long-term outcome in French patients","volume":"31","author":"Masurel-Paulet","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jhep.2013.04.004_b0345","first-page":"311","article-title":"Tyrosinemia: the Quebec experience","volume":"19","author":"Paradis","year":"1996","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0350","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1203\/00006450-199505000-00015","article-title":"The nephropathy of type I tyrosinemia after liver transplantation","volume":"37","author":"Laine","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jhep.2013.04.004_b0355","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1399-3046.2011.01497.x","article-title":"Liver transplantation for hereditary tyrosinemia type I: analysis of the UNOS database","volume":"15","author":"Arnon","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0360","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/01.tp.0000185194.62108.a7","article-title":"Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation","volume":"81","author":"Herzog","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.04.004_b0365","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/PL00014321","article-title":"Indications and outcome of liver transplantation in tyrosinaemia type 1","volume":"158","author":"Mohan","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jhep.2013.04.004_b0370","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/hep.1840040705","article-title":"Alpha-1-antitrypsin deficiency","volume":"4","author":"Alagille","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.004_b0375","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI4874","article-title":"Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis","volume":"103","author":"Mahadeva","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2013.04.004_b0380","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM197606102942404","article-title":"Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants","volume":"294","author":"Sveger","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0385","first-page":"514","article-title":"The liver in adolescents with alpha 1-antitrypsin deficiency","volume":"22","author":"Sveger","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.004_b0390","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-3-16","article-title":"Hereditary alpha-1-antitrypsin deficiency and its clinical consequences","volume":"3","author":"Fregonese","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2013.04.004_b0395","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1357-2725(02)00250-9","article-title":"Alpha(1)-antitrypsin deficiency, liver disease and emphysema","volume":"35","author":"Parfrey","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jhep.2013.04.004_b0400","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1432-2277.2000.tb01068.x","article-title":"Liver transplantation for alpha-1-antitrypsin deficiency in children","volume":"13","author":"Prachalias","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2013.04.004_b0405","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1399-0012.2010.01371.x","article-title":"Long-term outcome in 42 pediatric liver transplant patients with alpha 1-antitrypsin deficiency: a single-center experience","volume":"25","author":"Hughes","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0410","first-page":"4","article-title":"Effect of liver transplant on pulmonary functions in adult patients with alpha 1 antitrypsin deficiency: 7 cases","volume":"8","author":"Jain","year":"2010","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0415","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.transproceed.2008.02.075","article-title":"Alpha-1-antitrypsin deficiency: outcomes after liver transplantation","volume":"40","author":"Kemmer","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2013.04.004_b0420","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2010.05.010","article-title":"Barriers to the successful treatment of liver disease by hepatocyte transplantation","volume":"53","author":"Soltys","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.04.004_b0425","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e31823b72d6","article-title":"Current status of hepatocyte transplantation","volume":"93","author":"Hughes","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.04.004_b0430","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/lt.22443","article-title":"Domino liver transplantation: how far can we push the paradigm?","volume":"18","author":"Popescu","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.04.004_b0435","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/13506129.2011.574354065","article-title":"Symptomatic and proven de novo amyloid polyneuropathy in familial amyloid polyneuropathy domino liver recipients","volume":"18","author":"Adams","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.jhep.2013.04.004_b0440","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/MOT.0b013e32834a94cf","article-title":"Auxiliary liver transplantation in children","volume":"16","author":"Ciria","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0445","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1111\/j.1600-6143.2005.01084.x","article-title":"Living donor liver transplantation for pediatric patients with inheritable metabolic disorders","volume":"5","author":"Morioka","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0450","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1399-3046.2012.01733.x","article-title":"Ornithine transcarbamylase deficiency: are carrier females suitable donors?","volume":"16","author":"Wong","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0455","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1111\/j.1399-3046.2012.01716.x","article-title":"Living donor liver transplantation from an asymptomatic mother who was a carrier for ornithine transcarbamylase deficiency","volume":"16","author":"Wakiya","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0905","doi-asserted-by":"crossref","unstructured":"Summar M. Urea cycle disorders. In: Sucky FJ, Sokol RJ, Balistrieri WF, editors. Liver disease in children, 3rd ed. Frederick J. Suchy, Ronald J. Sokol, William F. Balistreri. Cambridge University Press:Cambridge; 2007.","DOI":"10.1017\/CBO9780511547409.038"},{"key":"10.1016\/j.jhep.2013.04.004_b0465","first-page":"836","article-title":"The clinical, biochemical, and molecular spectrum of ornithine transcarbamylase deficiency","volume":"120","author":"Tuchman","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0470","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00431-003-1347-z","article-title":"Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation","volume":"162","author":"Bachmann","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jhep.2013.04.004_b0890","doi-asserted-by":"crossref","first-page":"1605S","DOI":"10.1093\/jn\/134.6.1605S","article-title":"Clinical manifestations of inborn errors of the urea cycle and related metabolic disorders during childhood","volume":"134","author":"Endo","year":"2004","journal-title":"J Nutr"},{"key":"10.1016\/j.jhep.2013.04.004_b0480","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM199609193351204","article-title":"Long-term treatment of girls with ornithine transcarbamylase deficiency","volume":"335","author":"Maestri","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0485","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1067\/mpd.2001.111838","article-title":"Long-term correction of urea cycle disorders","volume":"138","author":"Lee","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2013.04.004_b0490","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.ymgme.2003.08.027","article-title":"The role of liver transplantation in urea cycle disorders","volume":"81","author":"Leonard","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jhep.2013.04.004_b0495","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.ymgme.2010.02.012","article-title":"Early orthotopic liver transplantation in urea cycle defects: follow up of a developmental outcome study","volume":"100","author":"Campeau","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jhep.2013.04.004_b0500","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1023\/A:1005317909946","article-title":"Liver transplantation for the treatment of urea cycle disorders","volume":"21","author":"Whitington","year":"1998","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jhep.2013.04.004_b0505","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1399-3046.2011.01494.x","article-title":"Living donor liver transplantation for ornithine transcarbamylase deficiency","volume":"15","author":"Wakiya","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0510","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1399-3046.2010.01402.x","article-title":"Living-donor liver transplantation for carbamoyl phosphate synthetase 1 deficiency","volume":"14","author":"Kasahara","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0515","first-page":"169","article-title":"Congenital familial nonhemolytic jaundice with kernicterus","volume":"10","author":"Crigler","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhep.2013.04.004_b0520","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z","article-title":"Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype","volume":"16","author":"Kadakol","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jhep.2013.04.004_b0525","first-page":"259","article-title":"Nonhemolytic unconjugated hyperbilirubinemia with hepatic glucuronyl transferase deficiency: a genetic study in four generations","volume":"80","author":"Sleisenger","year":"1967","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.jhep.2013.04.004_b0530","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0002-9343(69)90224-1","article-title":"Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity","volume":"47","author":"Arias","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0535","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510240205","article-title":"Current therapy for Crigler-Najjar syndrome type 1: report of a world registry","volume":"24","author":"van der Veere","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.004_b0540","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1067\/S0022-3476(03)00298-1","article-title":"Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats","volume":"143","author":"Nishioka","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2013.04.004_b0545","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0022-3476(74)80408-7","article-title":"Influence of phototherapy on the biliary bilirubin excretion pattern in newborn infants with hyperbilirubinemia","volume":"85","author":"Lund","year":"1974","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2013.04.004_b0550","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1073\/pnas.0500930102","article-title":"Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector","volume":"102","author":"Toietta","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.04.004_b0555","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJM199805143382004","article-title":"Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation","volume":"338","author":"Fox","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0560","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0098-2997(87)90009-4","article-title":"Crigler-Najjar syndrome types I and II. Clinical experience\u2013King-s College Hospital 1972\u20131978. Phenobarbitone, phototherapy and liver transplantation","volume":"9","author":"Pett","year":"1987","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0565","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00007890-199511270-00006","article-title":"Orthotopic liver transplantation for Crigler-Najjar type I disease in six children","volume":"60","author":"Sokal","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.04.004_b0570","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0041-1345(96)00179-0","article-title":"Orthotopic liver transplantation for Crigler-Najjar type I syndrome","volume":"29","author":"Gridelli","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2013.04.004_b0575","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00000658-199904000-00017","article-title":"Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I","volume":"229","author":"Rela","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2013.04.004_b0580","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2183\/pjab.86.694","article-title":"Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967\u20132010)","volume":"86","author":"Araki","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.jhep.2013.04.004_b0585","doi-asserted-by":"crossref","first-page":"e24850","DOI":"10.1371\/journal.pone.0024850","article-title":"Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen\u2019s chaperone activity","volume":"6","author":"da Costa","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.04.004_b0590","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00019052-199610000-00007","article-title":"Familial amyloid polyneuropathy: new developments in genetics and treatment","volume":"9","author":"Coelho","year":"1996","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jhep.2013.04.004_b0895","doi-asserted-by":"crossref","DOI":"10.1002\/mus.23665","article-title":"Is it better than it seems or just good enough? The tafamidis saga","author":"de Carvalho","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jhep.2013.04.004_b0600","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/WNL.0b013e318248df18","article-title":"Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy","volume":"78","author":"Yamashita","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jhep.2013.04.004_b0605","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/jlts.2002.29764","article-title":"Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil","volume":"8","author":"Bittencourt","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.04.004_b0610","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.TP.0000092307.98347.CB","article-title":"Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry","volume":"77","author":"Herlenius","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.04.004_b0615","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/lt.21996","article-title":"Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience","volume":"16","author":"Barreiros","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.04.004_b0620","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00595-010-4488-5","article-title":"Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation","volume":"41","author":"Ohya","year":"2011","journal-title":"Surg Today"},{"key":"10.1016\/j.jhep.2013.04.004_b0625","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autneu.2010.04.007","article-title":"Cardiac autonomic function does not improve after liver transplantation for familial amyloidotic polyneuropathy","volume":"156","author":"Wiklund","year":"2010","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jhep.2013.04.004_b0630","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/TP.0b013e31824b3749","article-title":"Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosis","volume":"93","author":"Gustafsson","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.04.004_b0635","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/13506129.2011.615872","article-title":"Development of cardiomyopathy after liver transplantation in Swedish hereditary transthyretin amyloidosis (ATTR) patients","volume":"18","author":"Okamoto","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.jhep.2013.04.004_b0640","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/lt.22019","article-title":"Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report","volume":"16","author":"Muller","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.04.004_b0645","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1432-2277.2008.00737.x","article-title":"High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy","volume":"22","author":"Bispo","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2013.04.004_b0650","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejcts.2007.03.023","article-title":"Combined heart and liver transplantation for familial amyloidotic neuropathy","volume":"32","author":"Pilato","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jhep.2013.04.004_b0655","first-page":"e48","article-title":"Combined heart-liver transplantation with extended cardiopulmonary bypass","volume":"52","author":"Marriott","year":"2011","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jhep.2013.04.004_b0910","unstructured":"Coulter-Mackie MB, White CT, Hurley RM, Chew BH, Lange D. Primary Hyperoxaluria Type 1. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. Source GeneReviews\u2122 [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132013. 2002 Jun 19 [updated 2011 Nov 17]."},{"key":"10.1016\/j.jhep.2013.04.004_b0665","first-page":"4","article-title":"The clinical spectrum of the primary hyperoxalurias and their treatment","volume":"11","author":"Watts","year":"1998","journal-title":"J Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0670","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ndt\/18.2.273","article-title":"Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome","volume":"18","author":"van Woerden","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0675","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000086358","article-title":"Primary hyperoxaluria\u2013the German experience","volume":"25","author":"Hoppe","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0680","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MOT.0b013e32833e35f5","article-title":"Primary hyperoxaluria type 1: strategy for organ transplantation","volume":"15","author":"Cochat","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0685","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.semnephrol.2008.01.008","article-title":"The primary hyperoxalurias","volume":"28","author":"Bobrowski","year":"2008","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0690","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ki.2009.32","article-title":"The primary hyperoxalurias","volume":"75","author":"Hoppe","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2013.04.004_b0695","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ki.2009.237","article-title":"Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1","volume":"76","author":"Fargue","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2013.04.004_b0700","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1681\/ASN.V1291986","article-title":"The primary hyperoxalurias","volume":"12","author":"Leumann","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0705","first-page":"49","article-title":"Pyridoxine-responsive PH1: treatment","volume":"11","author":"Toussaint","year":"1998","journal-title":"J Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0710","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000060176","article-title":"The primary hyperoxalurias","author":"Marangella","year":"2001","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0715","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1034\/j.1399-3046.2000.00107.x","article-title":"Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1","volume":"4","author":"Nolkemper","year":"2000","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0720","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00467-010-1593-z","article-title":"Excellent renal function and reversal of nephrocalcinosis 8 years after isolated liver transplantation in an infant with primary hyperoxaluria type 1","volume":"25","author":"Galanti","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0725","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00467-010-1594-y","article-title":"Liver transplantation in oxalosis prior to advanced chronic kidney disease","volume":"25","author":"Scheinman","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0730","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00240-005-0495-1","article-title":"The role of preemptive liver transplantation in primary hyperoxaluria type 1","volume":"33","author":"Kemper","year":"2005","journal-title":"Urol Res"},{"key":"10.1016\/j.jhep.2013.04.004_b0735","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1111\/j.1600-6143.2010.03271.x","article-title":"Transplantation outcomes in primary hyperoxaluria","volume":"10","author":"Bergstralh","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0740","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0745","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0750","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0002-9343(99)00286-7","article-title":"Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"107","author":"Lara","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2013.04.004_b0755","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1067\/mpd.2001.112649","article-title":"Familial hemolytic uremic syndrome associated with complement factor H deficiency","volume":"138","author":"Landau","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2013.04.004_b0760","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2013.04.004_b0765","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background","volume":"1","author":"Bresin","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0770","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1399-3046.2008.00910.x","article-title":"Hemolytic uremic syndrome recurrence after renal transplantation","volume":"12","author":"Loirat","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0775","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(02)08560-4","article-title":"Combined kidney and liver transplantation for familial haemolytic uraemic syndrome","volume":"359","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.04.004_b0780","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1681\/ASN.2008080906","article-title":"Liver-kidney transplantation to cure atypical hemolytic uremic syndrome","volume":"20","author":"Saland","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0785","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2005.00783.x","article-title":"Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation","volume":"5","author":"Remuzzi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0790","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1600-6143.2006.01375.x","article-title":"Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation","volume":"6","author":"Saland","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0795","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-6143.2007.02029.x","article-title":"Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H","volume":"8","author":"Jalanko","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0800","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2215\/CJN.02170508","article-title":"Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome","volume":"4","author":"Saland","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0805","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00467-008-0872-4","article-title":"Complement and the atypical hemolytic uremic syndrome in children","volume":"23","author":"Loirat","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0810","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00467-003-1371-2","article-title":"Attempted treatment of factor H deficiency by liver transplantation","volume":"19","author":"Cheong","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0815","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1600-6143.2010.03228.x","article-title":"Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H","volume":"10","author":"Haller","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0900","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/siny.2001.0087","article-title":"Branched-chain organic acidurias","volume":"7","author":"Ogier de Baulny","year":"2002","journal-title":"Semin Neonatol"},{"key":"10.1016\/j.jhep.2013.04.004_b0825","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s004670100702","article-title":"Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators","volume":"16","author":"Picca","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jhep.2013.04.004_b0830","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1005668431926","article-title":"Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises","volume":"23","author":"Wajner","year":"2000","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jhep.2013.04.004_b0835","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MPG.0b013e3181132252","article-title":"Recurrent acute pancreatitis associated with propionic acidemia","volume":"47","author":"Bultron","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2013.04.004_b0840","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-6143.2005.01209.x","article-title":"Elective liver transplantation for the treatment of classical maple syrup urine disease","volume":"6","author":"Strauss","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0845","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1399-3046.2006.00585.x","article-title":"Current role of liver transplantation for methylmalonic acidemia: a review of the literature","volume":"10","author":"Kasahara","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0850","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1111\/j.1600-6143.2007.01986.x","article-title":"Efficacy of living donor liver transplantation for patients with methylmalonic acidemia","volume":"7","author":"Morioka","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0855","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1399-3046.2006.00569.x","article-title":"Evaluation and management of patients with propionic acidemia undergoing liver transplantation: a comprehensive review","volume":"10","author":"Barshes","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0860","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-3046.2011.01607.x","article-title":"Living-donor liver transplantation for propionic acidemia","volume":"16","author":"Kasahara","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0865","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/lt.22279","article-title":"Liver transplantation for propionic acidemia in children","volume":"17","author":"Vara","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.04.004_b0870","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1600-6143.2007.01899.x","article-title":"Auxiliary liver transplantation for propionic acidemia: a 10-year follow-up","volume":"7","author":"Rela","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.04.004_b0875","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00431-002-0970-4","article-title":"Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver","volume":"161","author":"Nyhan","year":"2002","journal-title":"Eur J Pediatr"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813002195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813002195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T03:41:22Z","timestamp":1745984482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813002195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":175,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0168827813002195"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.04.004","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}